logo

For the Inventor, By the Inventor

Gales Ferry, CT, United States of America

Bruce A Lefker

USPTO Granted Patents = 50 

Average Co-Inventor Count = 3.7

ph-index = 9

Forward Citations = 269(Granted Patents)

Forward Citations (Not Self Cited) = 251(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:

goldMedal48 out of 4,455 
 
Pfizer Corporation
 patents
silverMedal2 out of 2,538 
 
Warner-lambert Company
 patents

Years Active: 1995-2013

Loading Chart...
Areas of Expertise:
Dibenzyl Amine Compounds
Androgen Modulators
EP4 Receptor Selective Agonists
Prostaglandin Agonists
Dipeptide Derivatives
Growth Hormone Secretagogues
Osteoporosis Compounds
Heterocyclic Compounds
Insulin Resistance Treatment
Skeletal Disorder Treatment
Estrogen Agonists
Renin Inhibitors
50 patents (USPTO):Explore Patents
1. 8383660 - Dibenzyl amine compounds and derivatives (2013-02-26),
2. 7919506 - Dibenzyl amine compounds and derivatives (2011-04-05),
3. 7799823 - Androgen modulators (2010-09-21),
4. 7674819 - Androgen modulators (2010-03-09),
5. 7670613 - Androgen modulators (2010-03-02),
6. 7576128 - Androgen receptor modulators (2009-08-18),
7. 7507860 - Androgen modulators (2009-03-24),
8. 7507732 - Cyclopentapyridine and tetrahydroquinoline derivatives (2009-03-24),
9. 7473711 - Androgen modulators (2009-01-06),
10. 7442702 - Prostaglandin agonists (2008-10-28),
11. 7414071 - Methods of treatment with selective EP4 receptor agonists (2008-08-19),
12. 7192979 - EP4 receptor selective agonist in the treatment of osteoporosis (2007-03-20),
13. 6998423 - Prevention of loss and restoration of bone mass by certain prostaglandin agonists (2006-02-14),
14. 6953791 - Dipeptide derivatives (2005-10-11),
15. 6951850 - Dipeptide derivatives (2005-10-04),

Title: Bruce A Lefker - Pioneering Innovator in Pharmaceutical Compositions

Introduction:

Bruce A Lefker, a prolific inventor from Gales Ferry, CT, has made significant contributions to the field of pharmaceutical compositions with his groundbreaking inventions.

Latest Patents:

Among his impressive portfolio of 50 patents, Bruce A Lefker's latest patents involve Dibenzyl amine compounds and derivatives. These compounds have been developed to target specific plasma lipid levels, such as HDL-cholesterol, LDL-cholesterol, and triglycerides, with the aim of treating diseases like atherosclerosis and cardiovascular conditions.

Career Highlights:

Bruce A Lefker has been associated with renowned companies in the pharmaceutical industry, including Pfizer Corporation and Warner-Lambert Company. His innovative work has led to advancements in the development of medications that address critical health issues related to lipid levels and cardiovascular diseases.

Collaborations:

During his esteemed career, Bruce A Lefker has collaborated with esteemed professionals in the field. Notable colleagues include Philip Albert Carpino and Kimberly O Cameron, who have worked alongside him to bring his inventions to fruition.

Conclusion:

In conclusion, Bruce A Lefker stands as a pioneering figure in the realm of pharmaceutical compositions, with a remarkable track record of patents that have the potential to positively impact healthcare outcomes. His dedication to innovation and his collaborations with industry peers underscore his commitment to advancing the field of medicine through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…